P
Pedro I. S. Maia
Researcher at University of São Paulo
Publications - 71
Citations - 1458
Pedro I. S. Maia is an academic researcher from University of São Paulo. The author has contributed to research in topics: Ruthenium & Ligand. The author has an hindex of 19, co-authored 62 publications receiving 1179 citations. Previous affiliations of Pedro I. S. Maia include University of Brasília.
Papers
More filters
Journal ArticleDOI
Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/ hydrazones: Anti - Mycobacterium tuberculosis activity and cytotoxicity
Fernando Rogério Pavan,Pedro I. S. Maia,Sergio Roberto de Andrade Leite,Victor M. Deflon,Alzir A. Batista,Daisy N. Sato,Scott G. Franzblau,Clarice Queico Fujimura Leite +7 more
TL;DR: The results are comparable to or better than those of "first line" or "second line" drugs commonly used to treat TB, suggesting these compounds as anti-TB drug candidates.
Journal ArticleDOI
Stress and burnout among Portuguese anaesthesiologists.
TL;DR: The prevalence of depersonalisation was extremely high in the studied sample of Portuguese anaesthesiologists, partially explained by high perceived‐stress and low satisfaction with organisation in the job according to Pressure Management Indicator scale.
Journal ArticleDOI
Vanadium complexes with thiosemicarbazones: Synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity
Pedro I. S. Maia,Fernando Rogério Pavan,Clarice Queico Fujimura Leite,Sebastião S. Lemos,Gerimário F. de Sousa,Alzir A. Batista,Otaciro R. Nascimento,Javier Ellena,Eduardo E. Castellano,Elke Niquet,Victor M. Deflon +10 more
TL;DR: In this paper, three oxovanadium-IV and three cis-dioxovanadium(V) complexes with thiosemicarbazone derivatives bearing moieties with different lipophilicity have been prepared and had their inhibitory activity against Mycobacterium tuberculosis H37Rv ATCC 27294 evaluated.
Journal ArticleDOI
Dithiocarbazate complexes with the [M(PPh3)]2+ (M═Pd or Pt) moiety: Synthesis, characterization and anti-Tripanosoma cruzi activity
Pedro I. S. Maia,André Fernandes,Jean Jerley Nogueira da Silva,Adriano D. Andricopulo,Sebastião S. Lemos,Ernesto Schulz Lang,Ulrich Abram,Victor M. Deflon +7 more
TL;DR: These complexes exhibited biological activity on extra and intracellular forms of Trypanosoma cruzi in a time- and concentration-dependent manner with IC(50) values ranging from 7.8 to 18.7 μM, while the ligand H(2)L(2a) presented a trypanocidal activity on trypomastigote form better than the standard drug benznidazole.
Journal ArticleDOI
Gold(III) complexes in medicinal chemistry
TL;DR: A number of gold(III) compounds has been designed with the objective of overcoming the disadvantages associated with the platinum-based drugs for cancer treatment, and many studies show evidence that the cellular targets are mitochondria-based.